Articles Vol. 66 No. CĐ14-HNKH BV Giao thông Vận tải 12/01/2026

26. STEM CELLS - APPLICATIONS RELATED TO MALE & FEMALE REPRODUCTIVE ORGANS

Pham Xuan Da1,2,3,4, Nguyen Thi Mai Phuong2,5, Nguyen Van Dung1,6
1 University of Medicine and Pharmacy, Vietnam National University, Hanoi
2 2) Transport Hospital.
3 1) Trường Đại học Y Dược, Đại học Quốc gia Hà Nội
4 2) Bệnh viện Giao thông vận tải
5 2) Bệnh viện Giao thông vận tải.
6 1) Trường Đại học Y Dược, Đại học Quốc gia Hà Nộ
Corresponding author: drdavn@gmail.com
DOI: 10.52163/yhc.v66iCD14.3078
22 Views
17 Downloads
Keywords
Stem cell, reproductive organs, application
Abstract

Humans are formed from the first stem cell (embryo) which then multiplies and differentiates into a complete human body consisting of 220 organs and about 37 to 40 trillion cells. Stem cells are cells that have the ability to reproduce and differentiate into cells of organs in the body. By means of a comprehensive literature review, it is shown that: Using induced pluripotent stem cell (iPSC) therapy, mesenchymal stem cells (MSC) have been proven effective in treating female infertility, prolonging youth. hiPS (Human Induced Pluripotent Stem) stem cell lines are used to treat patients with Kline-feder syndrome and azoospermia with Y chromosome azoospermia. Research directions for restoring fertility with stem cells include: (1) Expanding spermatogonial stem cells (SSC) in vitro and then autotransplanting testes; (2) Automated whole testicular biopsy transfer; (3) In vitro spermatogenesis.

References
[1]
Cox CA-OX, Thoma MA-O, Tchangalova NA-O, Mburu GA-O, Bornstein MA-O, Johnson CA-O, et al. Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis. Hum Reprod Open, 2022, 4: hoac051. Google Scholar
[2]
Esfandyari S, Chugh RM, Park HS, Hobeika E, Ulin MA-O, Al-Hendy A. Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. LID - 10.3390/cells9102253 [doi] LID - 2253. Cells, 2020, 9(10): 2253. Google Scholar
[3]
Fasching LA-OX, Jang YA-O, Tomasi S, Schreiner JA-O, Tomasini LA-O, Brady MA-O, et al. Early developmental asymmetries in cell lineage trees in living individuals. Science, 2021, 371(6535): 1245-8. Google Scholar
[4]
Schwartz SD, Hubschman J-P, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. The Lancet, 2012, 379(9817): 713-20. Google Scholar
[5]
Pickering SJ, Braude Pr Fau - Patel M, Patel M Fau - Burns CJ, Burns Cj Fau - Trussler J, Trussler J Fau - Bolton V, Bolton V Fau - Minger S, et al. Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod Biomed Online, 2003, 7(3): 353-64. Google Scholar
[6]
Xie Y, Liu W, Liu S, Wang L, Mu D, Cui Y, et al. The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products. Stem Cell Res Ther, 2020, 11(1): 176. Google Scholar
[7]
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Research & Therapy, 2018, 9(1): 192. Google Scholar
[8]
Santamaria X, Cabanillas S, Cervelló I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod 2016, 31(5): 1087-96. Google Scholar
[9]
Vassena R, Eguizabal C, Heindryckx B, Sermon K, Simon C, van Pelt AM, et al. Stem cells in reproductive medicine: ready for the patient? Hum Reprod, 2015, 30(9): 2014-21. Google Scholar
[10]
Gauthier-Fisher A, Kauffman A, Librach CA-O. Potential use of stem cells for fertility preservation. Andrology, 2020, 8(4): 862-78. Google Scholar